Affinia Therapeutics Inc. Contracts & Agreements
11 Contracts & Agreements
- Business Finance (1 contract)
- Business Operations (4)
- Human Resources (2)
- Intellectual Property (1)
- Uncategorized (3)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated April 20, 2021 (Filed With SEC on January 4, 2022)
- Exclusive License Agreement, by and among the Registrant, Massachusetts Eye and Ear Infirmary, the Schepens Eye Research Institute, Inc. and Lonza Houston, Inc., dated September... (Filed With SEC on January 4, 2022)
- Strategic Collaboration and License Agreement by and between the Registrant and Vertex Pharmaceuticals Incorporated., dated as of April 14, 2020 (Filed With SEC on January 4, 2022)
- Collaboration Agreement by and among the Registrant and Rheinische Friedrich-Wilhelms-Universitt Bonn and Universittsklinikum Bonn, dated as of June 11, 2021 (Filed With SEC on January 4, 2022)
- Option Agreement by and among the Registrant and Rheinische Friedrich-Wilhelms-Universitt Bonn and Universittsklinikum Bonn, dated as of June 11, 2021 (Filed With SEC on January 4, 2022)
- Sponsored Research Collaboration Agreement by and between the Registrant and The Institute of Molecular and Clinical Ophthalmology Basel, dated as of June 22, 2021 (Filed With SEC on January 4, 2022)
- Manufacturing Services Agreement by and between the Registrant and Lonza Houston, Inc., dated as of April 30, 2021, as amended on August 9, 2021 (Filed With SEC on January 4, 2022)
- 2019 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (as amended) (Filed With SEC on January 4, 2022)
- Employment Agreement by and between the Registrant and Rick Modi, dated as of August 27, 2019 (Filed With SEC on January 4, 2022)
- Offer Letter by and between the Registrant and Charles Albright, dated as of December 20, 2020 (Filed With SEC on January 4, 2022)
- Offer Letter by and between the Registrant and Thomas Leggett, dated as of November 16, 2021 (Filed With SEC on January 4, 2022)
